Organization · Venture Capital
Greenleaf Ventures
Greenleaf Ventures is a U.S.-based investment firm founded in 2000, focusing on control equity investments in established healthcare businesses. The firm aims to drive sustainable growth and innovation in the healthcare sector.
Overview
What Greenleaf Ventures does
What Greenleaf Ventures is
Greenleaf Ventures is a U.S.-based investment firm founded in 2000, focusing on control equity investments in established healthcare businesses. The firm aims to drive sustainable growth and innovation in the healthcare sector.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2000
- Approximate age
- About 26 years
- Structured capabilities
- Funder
- Last reviewed
- March 18, 2026
Official channels
Find Greenleaf Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Greenleaf Ventures as a funder
Investment thesis
Greenleaf Ventures focuses on transforming healthcare through strategic investments and hands-on leadership, aiming to drive sustainable growth and innovation in the sector.
Focus narrative
Greenleaf Ventures specializes in control equity investments in established healthcare businesses, targeting early-stage and growth-focused companies. The firm aims to drive sustainable growth, operational excellence, and innovation by providing resources, expertise, and funding. The investment range is between $10 million and $50 million per opportunity.
Value beyond capital
Greenleaf Ventures adds value to its portfolio companies through hands-on leadership, operational expertise, and strategic guidance, helping them achieve sustainable growth and innovation in the healthcare sector.
Terms and economics
- Typical check
- $10,000,000–$50,000,000
Focus and fit
- Stages
- Seed · Series A · Series B · Growth Equity
- Sectors
- Consumer
- Regions
- United States
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 7
- Recorded notable exits
- Access Diabetic Supply, AmeriMedRx, Arriva Medical, and Comfort Medical
Portfolio context
Notable portfolio companies include: Aptiva Medical: Specializes in continuous glucose monitoring devices and support services for diabetes care. AptivaRx: An online pharmacy providing immunosuppressant and respiratory medications for chronic conditions. Sterling Distributors: Distributor of medical supplies and equipment, focusing on quality and affordability. Access Diabetic Supply: Exited in 2005, it was a leading provider of diabetic testing supplies. AmeriMedRx: Exited in 2001, it offered innovative medical products aimed at improving patient outcomes. Arriva Medical: Exited in 2011, specialized in mail-order diabetic testing supplies. Comfort Medical: Exited in 2016, supplied catheter and ostomy products with a focus on quality and customer care.
Common questions
What to know about Greenleaf Ventures
Upseed classifies Greenleaf Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 18, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.